Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is well-positioned to benefit from the increasing demand for medical technology products that improve patient outcomes, reduce costs, and improve safety. Their strong presence in the Americas and growing presence in EMEA and Asia make them a global player in the market. The upcoming results of the BIOMAG-II trial and potential changes to the European Society of Cardiology guidelines could lead to increased sales for their innovative products, further driving growth and profitability.

Bears say

Teleflex is expected to see mid-single digit growth due to its Interventional business, however, its recent 2Q results have shown issues with this segment and overall revenue growth. Additionally, its cost reduction efforts may not be enough to offset these challenges and achieve the desired margin improvements and double-digit earnings growth. This, combined with its high reliance on the Americas for revenue, is concerning for the company's long-term viability.

Teleflex (TFX) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 10 analysts, Teleflex (TFX) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $153, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $153, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.